Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes
Vincenzo Di Marzo, Fabiana Piscitelli, Raphael Mechoulam
Handbook of experimental pharmacology (2011), pp. 75-104
Closed Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

Cannabis, a complex plant: different compounds and different effects on individuals
Zerrin Atakan
Therapeutic Advances in Psychopharmacology (2012) Vol. 2, Iss. 6, pp. 241-254
Open Access | Times Cited: 483
Molecular pathways in non-alcoholic fatty liver disease
Teresa Auguet, Alba Berlanga, Esther Guiu‐Jurado, et al.
Clinical and Experimental Gastroenterology (2014), pp. 221-221
Open Access | Times Cited: 372
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science
Eric P. Baron
Headache The Journal of Head and Face Pain (2018) Vol. 58, Iss. 7, pp. 1139-1186
Closed Access | Times Cited: 211
An Overview of Herbal Products and Secondary Metabolites Used for Management of Type Two Diabetes
Ajda Ota, Nataša Poklar Ulrih
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 199
Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …
Eric P. Baron
Headache The Journal of Head and Face Pain (2015) Vol. 55, Iss. 6, pp. 885-916
Open Access | Times Cited: 189
Endocannabinoid system and mood disorders: Priming a target for new therapies
Vincenzo Micale, Vincenzo Di Marzo, Alexandra Šulcová, et al.
Pharmacology & Therapeutics (2012) Vol. 138, Iss. 1, pp. 18-37
Closed Access | Times Cited: 202
Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence
Cecilia J. Hillard, Kenneth M. Weinlander, Kara L. Stuhr
Neuroscience (2011) Vol. 204, pp. 207-229
Open Access | Times Cited: 173
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort
Eric P. Baron, Philippe Lucas, Joshua Eades, et al.
The Journal of Headache and Pain (2018) Vol. 19, Iss. 1
Open Access | Times Cited: 159
At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction
Fabrizio Montecucco, Vincenzo Di Marzo
Trends in Pharmacological Sciences (2012) Vol. 33, Iss. 6, pp. 331-340
Open Access | Times Cited: 155
The association between cannabis use and mood disorders: A longitudinal study
Daniel L. Feingold, Mark Weiser, Jürgen Rehm, et al.
Journal of Affective Disorders (2014) Vol. 172, pp. 211-218
Closed Access | Times Cited: 150
Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System
John M. McPartland, Geoffrey W. Guy, Vincenzo Di Marzo
PLoS ONE (2014) Vol. 9, Iss. 3, pp. e89566-e89566
Open Access | Times Cited: 141
Endogenous cannabinoids revisited: A biochemistry perspective
Bruno M. Fonseca, M.A. Costa, Marta Almada, et al.
Prostaglandins & Other Lipid Mediators (2013) Vol. 102-103, pp. 13-30
Closed Access | Times Cited: 138
Human β-Cell Proliferation and Intracellular Signaling: Part 3
Andrew F. Stewart, Mehboob A. Hussain, Adolfo Garcı́a-Ocaña, et al.
Diabetes (2015) Vol. 64, Iss. 6, pp. 1872-1885
Open Access | Times Cited: 133
Endocannabinoids Measurement in Human Saliva as Potential Biomarker of Obesity
Isabel Matias, Blandine Gatta-Chérifi, Antoine Tabarin, et al.
PLoS ONE (2012) Vol. 7, Iss. 7, pp. e42399-e42399
Open Access | Times Cited: 129
Cannabinoids and autoimmune diseases: A systematic review
Valeria Katchan, Paula David, Yehuda Shoenfeld
Autoimmunity Reviews (2016) Vol. 15, Iss. 6, pp. 513-528
Closed Access | Times Cited: 129
Endocannabinoids limit excessive mast cell maturation and activation in human skin
Koji Sugawara, Tamás Bı́ró, Daisuke Tsuruta, et al.
Journal of Allergy and Clinical Immunology (2012) Vol. 129, Iss. 3, pp. 726-738.e8
Open Access | Times Cited: 127
CUA guideline: Diagnosis and treatment of interstitial cystitis/ bladder pain syndrome
Ashley Cox, Nicole Golda, Geneviève Nadeau, et al.
Canadian Urological Association Journal (2016) Vol. 10, Iss. 5-6, pp. 136-136
Open Access | Times Cited: 127
Type 2 Diabetes Associated Changes in the Plasma Non-Esterified Fatty Acids, Oxylipins and Endocannabinoids
Dmitry Grapov, Sean H. Adams, Theresa L. Pedersen, et al.
PLoS ONE (2012) Vol. 7, Iss. 11, pp. e48852-e48852
Open Access | Times Cited: 125
Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation
Daniel J. Hermanson, Nolan D. Hartley, Joyonna Gamble‐George, et al.
Nature Neuroscience (2013) Vol. 16, Iss. 9, pp. 1291-1298
Open Access | Times Cited: 116
Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors
Gemma Navarro, Katia Varani, Alejandro Lillo, et al.
Pharmacological Research (2020) Vol. 159, pp. 104940-104940
Open Access | Times Cited: 76
Alterations of specific lipid groups in serum of obese humans: a review
Adriana Mika, Tomasz Śledziński
Obesity Reviews (2016) Vol. 18, Iss. 2, pp. 247-272
Closed Access | Times Cited: 75
The endocannabinoid system modulates stress, emotionality, and inflammation
Molly S. Crowe, Sara R. Nass, Kristin M. Gabella, et al.
Brain Behavior and Immunity (2014) Vol. 42, pp. 1-5
Closed Access | Times Cited: 67
Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats
Daniel I. Brierley, James Samuels, Marnie Duncan, et al.
Psychopharmacology (2016) Vol. 233, Iss. 19-20, pp. 3603-3613
Open Access | Times Cited: 61
The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity
Elsa Heyman, François-Xavier Gamelin, Julien Aucouturier, et al.
Obesity Reviews (2012) Vol. 13, Iss. 12, pp. 1110-1124
Closed Access | Times Cited: 66
Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ
Koji Sugawara, Nóra Zákány, Torsten Hundt, et al.
Journal of Allergy and Clinical Immunology (2013) Vol. 132, Iss. 1, pp. 182-193.e8
Open Access | Times Cited: 59
Page 1 - Next Page

Scroll to top